查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426951

消化不良药物市场- 适应症（功能性、有机）、药物类型（质子帮浦抑制剂、H-2-受体拮抗剂、抗酸剂、抗生素）、药物（品牌、仿製药）、模式（OTC、处方）、配销通路、全球预测（ 2024-2032）

Dyspepsia Drugs Market - Indication (Functional, Organic), Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics), Medication (Branded, Generic), Mode (OTC, Prescription), Distribution Channel, Global Forecast (2024-2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

由于不同族群消化系统疾病的发生率不断上升，预计 2024 年至 2032 年消化不良药物市场的CAGR将达到 4.5%。现代生活方式的特征是不稳定的饮食习惯、压力水平增加和久坐行为，导致消化问题激增，导致对消化不良药物的需求不断增长。

根据 2021 年全国医院门诊医疗调查，近 840 万人因消化系统问题前往急诊室就诊。人口老化更容易出现胃肠道问题，因此对先进、有效的消化不良药物产生了持续的需求。随着医疗保健意识的增强，患者寻求及时有效的解决方案，进一步刺激市场成长。

消化不良药物市场依据适应症、药物类型、用药、模式、配销通路和区域进行分类。

有机适应症领域预计 2024 年至 2032 年间CAGR将达到 4%。消费者越来越多地寻求自然和整体的方法来管理消化不适，从而推动对有机消化不良药物的需求。这种向有机解决方案的转变符合注重健康的消费者选择的更广泛趋势。因此，製药公司正在投资研发，以创造创新的有机消化不良药物，提供全面的治疗选择，以满足消费者不断变化的偏好。

2024 年和 2032 年，仿製药领域的CAGR将超过 5.8%，因为它们是为更广泛的患者群体提供的负担得起的替代品。随着几种消化不良品牌药物的专利到期，仿製药已变得普遍，在不影响疗效的情况下提供具有成本效益的解决方案。这不仅提高了可近性，而且还加剧了竞争，促进了创新并降低了整体治疗成本。随着全球医疗保健系统努力控製成本，仿製药领域将显着成长。

在消化系统疾病盛行率不断上升且积极主动的医疗基础设施的推动下，欧洲消化不良药物市场规模预计CAGR为 3.8%。由于饮食变化、生活方式因素和老化，欧洲人口的胃肠道问题正在激增。对医疗保健创新和研究的承诺导致了先进消化不良药物的开发。此外，严格的监管标准确保了这些药物的安全性和有效性，并增强了医疗保健提供者和患者的信心。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：消化不良药物市场洞察

  • 产业格局
  • 产业影响力
    • 成长动力
      • 消化不良盛行率增加
      • 人口老化加剧
      • 对非处方药 (OTC) 的偏好不断上升
    • 产业陷阱与挑战
      • 与消化不良药物相关的副作用
      • 替代疗法的可用性
  • 成长潜力分析
  • 监管环境
  • 定价分析
  • 流行病学
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章：消化不良药物市场估计与预测：按适应症，2018-2032

  • 主要动向：依指示
  • 功能性消化不良
  • 器质性消化不良

第 6 章：消化不良药物市场估计与预测：按药物类型，2018-2032

  • 主要动向：依药物类型
  • 质子帮浦抑制剂
  • H-2-受体拮抗剂
  • 抗酸剂
  • 抗生素
  • 促动力
  • 抗忧郁药

第 7 章：消化不良药物市场估计与预测：按药物分类，2018-2032

  • 主要动力向：透过药物治疗
  • 品牌化
  • 通用的

第 8 章：消化不良药物市场估计与预测：按模式，2018-2032

  • 主要动向：按模式
  • 在柜檯
  • 处方

第 9 章：消化不良药物市场估计与预测：按配销通路，2018-2032

  • 主要动向：按配销通路
  • 零售药局
  • 医院药房
  • 网路药局

第 10 章：消化不良药物市场估计与预测：按地区，2018 - 2032

  • 主要动向：按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 11 章：公司简介

  • Takeda Pharmaceutical Company Limited
  • AstraZeneca plc
  • Salix Pharmaceuticals, Inc.
  • Abbott Laboratories
  • Pfizer Inc.
  • Sanofi SA
  • Procter & Gamble
  • Haleon plc
  • ANI Pharmaceuticals, Inc.
  • Dr Reddy's Laboratories Ltd.
Product Code: 7670

Dyspepsia Drugs Market is expected to witness 4.5% CAGR from 2024 to 2032 owing to the escalating incidence of digestive disorders across demographics. The modern lifestyle, characterized by erratic eating habits, increased stress levels, and sedentary behavior, has contributed to a surge in digestive issues, leading to a growing demand for dyspepsia medications.

According to the National Hospital Ambulatory Medical Care Survey 2021, nearly 8.4 million people visited emergency departments for digestive system issues. The aging population is more susceptible to gastrointestinal problems, creating a sustained need for advanced and efficient dyspepsia drugs. As healthcare awareness increases, patients seek prompt and effective solutions, further stimulating the market growth.

The dyspepsia drugs market is classified based on indication, drug type, medication, mode, distribution channel, and region.

The organic indication segment is anticipated to record 4% CAGR between 2024 and 2032. Consumers are increasingly seeking natural and holistic approaches to manage digestive discomfort, driving the demand for organic dyspepsia medications. This shift towards organic solutions aligns with the broader trend of health-conscious consumer choices. As a result, pharmaceutical companies are investing in R&D to create innovative organic dyspepsia drugs, offering a comprehensive range of treatment options to meet the evolving preferences of consumers.

The generic medication segment will observe more than 5.8% CAGR during 2024 and 2032 as they are affordable alternatives provided to a broader patient base. With the expiration of patents for several branded dyspepsia drugs, generic versions have become prevalent, offering cost-effective solutions without compromising efficacy. This has not only improved accessibility but has also intensified the competition, fostering innovation and driving down overall treatment costs. As healthcare systems worldwide strive for cost containment, the generic medication segment will record notable growth.

Europe dyspepsia drugs market size is predicted to observe 3.8% CAGR over the forecast, driven by the increasing prevalence of digestive disorders and a proactive healthcare infrastructure. European population is experiencing a surge in gastrointestinal issues due to dietary changes, lifestyle factors, and aging. The commitment to healthcare innovation and research is resulting in the development of advanced dyspepsia drugs. Moreover, stringent regulatory standards ensure the safety and efficacy of these medications, fostering confidence among both healthcare providers and patients.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Dyspepsia drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Indication trends
    • 2.1.4 Drug type trends
    • 2.1.5 Medication trends
    • 2.1.6 Mode trends
    • 2.1.7 Distribution channel trends

Chapter 3 Dyspepsia Drugs Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of dyspepsia
      • 3.2.1.2 Growing aging population
      • 3.2.1.3 Rising preference for over-the-counter (OTC) medications
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with the dyspepsia drugs
      • 3.2.2.2 Availability of alternative therapies
  • 3.3 Growth potential analysis
    • 3.3.1 By indication
    • 3.3.2 By drug type
    • 3.3.3 By medication
    • 3.3.4 By mode
    • 3.3.5 By distribution channel
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis
  • 3.6 Epidemiology
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2023
  • 4.3 Competitive analysis of major market players, 2023
  • 4.4 Competitive positioning matrix, 2023
  • 4.5 Strategic dashboard, 2023

Chapter 5 Dyspepsia Drugs Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)

  • 5.1 Key trends, by indication
  • 5.2 Functional dyspepsia
  • 5.3 Organic dyspepsia

Chapter 6 Dyspepsia Drugs Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)

  • 6.1 Key trends, by drug type
  • 6.2 Proton pump inhibitors
  • 6.3 H-2-receptor antagonists
  • 6.4 Antacids
  • 6.5 Antibiotics
  • 6.6 Prokinetics
  • 6.7 Antidepressants

Chapter 7 Dyspepsia Drugs Market Estimates and Forecast, By Medication, 2018-2032 (USD Million)

  • 7.1 Key trends, by medication
  • 7.2 Branded
  • 7.3 Generic

Chapter 8 Dyspepsia Drugs Market Estimates and Forecast, By Mode, 2018-2032 (USD Million)

  • 8.1 Key trends, by mode
  • 8.2 Over-the-counter
  • 8.3 Prescription

Chapter 9 Dyspepsia Drugs Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 9.1 Key trends, by distribution channel
  • 9.2 Retail pharmacies
  • 9.3 Hospital pharmacies
  • 9.4 Online pharmacies

Chapter 10 Dyspepsia Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East & Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

  • 11.1 Takeda Pharmaceutical Company Limited
  • 11.2 AstraZeneca plc
  • 11.3 Salix Pharmaceuticals, Inc.
  • 11.4 Abbott Laboratories
  • 11.5 Pfizer Inc.
  • 11.6 Sanofi SA
  • 11.7 Procter & Gamble
  • 11.8 Haleon plc
  • 11.9 ANI Pharmaceuticals, Inc.
  • 11.10 Dr Reddy's Laboratories Ltd.

Data Tables

  • TABLE 1. Market Revenue, by indication (2023)
  • TABLE 2. Market Revenue, by drug type (2023)
  • TABLE 3. Market Revenue, by medication (2023)
  • TABLE 4. Market Revenue, by mode (2023)
  • TABLE 5. Market Revenue, by distribution channel (2023)
  • TABLE 6. Market share, by region (2023)
  • TABLE 7. Global dyspepsia drugs market size, by region, 2018 - 2023 (USD Million)
  • TABLE 8. Global dyspepsia drugs market size, by region, 2024 - 2032 (USD Million)
  • TABLE 9. Global dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 10. Global dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 11. Global dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 12. Global dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 13. Global dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 14. Global dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 15. Global dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 16. Global dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 17. Global dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 18. Global dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 19. Industry impact forces
  • TABLE 20. Functional dyspepsia market size, 2018 - 2023 (USD Million)
  • TABLE 21. Functional dyspepsia market size, 2024 - 2032 (USD Million)
  • TABLE 22. Organic dyspepsia market size, 2018 - 2023 (USD Million)
  • TABLE 23. Organic dyspepsia market size, 2024 - 2032 (USD Million)
  • TABLE 24. Proton pump inhibitors market size, 2018 - 2023 (USD Million)
  • TABLE 25. Proton pump inhibitors market size, 2024 - 2032 (USD Million)
  • TABLE 26. H-2-receptor antagonists market size, 2018 - 2023 (USD Million)
  • TABLE 27. H-2-receptor antagonists market size, 2024 - 2032 (USD Million)
  • TABLE 28. Antacids market size, 2018 - 2023 (USD Million)
  • TABLE 29. Antacids market size, 2024 - 2032 (USD Million)
  • TABLE 30. Antibiotics market size, 2018 - 2023 (USD Million)
  • TABLE 31. Antibiotics market size, 2024 - 2032 (USD Million)
  • TABLE 32. Prokinetics market size, 2018 - 2023 (USD Million)
  • TABLE 33. Prokinetics market size, 2024 - 2032 (USD Million)
  • TABLE 34. Antidepressants market size, 2018 - 2023 (USD Million)
  • TABLE 35. Antidepressants market size, 2024 - 2032 (USD Million)
  • TABLE 36. Branded market size, 2018 - 2023 (USD Million)
  • TABLE 37. Branded market size, 2024 - 2032 (USD Million)
  • TABLE 38. Generic market size, 2018 - 2023 (USD Million)
  • TABLE 39. Generic market size, 2024 - 2032 (USD Million)
  • TABLE 40. Over-the-counter market size, 2018 - 2023 (USD Million)
  • TABLE 41. Over-the-counter market size, 2024 - 2032 (USD Million)
  • TABLE 42. Prescription market size, 2018 - 2023 (USD Million)
  • TABLE 43. Prescription market size, 2024 - 2032 (USD Million)
  • TABLE 44. Retail pharmacies market size, 2018 - 2023 (USD Million)
  • TABLE 45. Retail pharmacies market size, 2024 - 2032 (USD Million)
  • TABLE 46. Hospital pharmacies market size, 2018 - 2023 (USD Million)
  • TABLE 47. Hospital pharmacies market size, 2024 - 2032 (USD Million)
  • TABLE 48. Online pharmacies market size, 2018 - 2023 (USD Million)
  • TABLE 49. Online pharmacies market size, 2024 - 2032 (USD Million)
  • TABLE 50. North America dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 51. North America dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 52. North America dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 53. North America dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 54. North America dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 55. North America dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 56. North America dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 57. North America dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 58. North America dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 59. North America dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 60. North America dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 61. North America dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 62. U.S. dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 63. U.S. dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 64. U.S. dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 65. U.S. dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 66. U.S. dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 67. U.S. dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 68. U.S. dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 69. U.S. dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 70. U.S. dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 71. U.S. dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 72. Canada dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 73. Canada dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 74. Canada dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 75. Canada dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 76. Canada dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 77. Canada dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 78. Canada dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 79. Canada dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 80. Canada dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 81. Canada dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 82. Europe dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 83. Europe dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 84. Europe dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 85. Europe dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 86. Europe dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 87. Europe dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 88. Europe dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 89. Europe dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 90. Europe dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 91. Europe dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 92. Europe dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 93. Europe dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 94. Germany dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 95. Germany dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 96. Germany dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 97. Germany dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 98. Germany dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 99. Germany dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 100. Germany dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 101. Germany dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 102. Germany dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 103. Germany dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 104. UK dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 105. UK dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 106. UK dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 107. UK dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 108. UK dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 109. UK dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 110. UK dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 111. UK dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 112. UK dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 113. UK dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 114. France dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 115. France dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 116. France dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 117. France dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 118. France dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 119. France dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 120. France dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 121. France dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 122. France dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 123. France dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 124. Spain dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 125. Spain dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 126. Spain dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 127. Spain dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 128. Spain dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 129. Spain dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 130. Spain dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 131. Spain dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 132. Spain dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 133. Spain dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 134. Italy dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 135. Italy dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 136. Italy dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 137. Italy dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 138. Italy dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 139. Italy dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 140. Italy dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 141. Italy dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 142. Italy dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 143. Italy dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 144. Rest of Europe dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 145. Rest of Europe dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 146. Rest of Europe dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 147. Rest of Europe dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 148. Rest of Europe dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 149. Rest of Europe dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 150. Rest of Europe dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 151. Rest of Europe dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 152. Rest of Europe dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 153. Rest of Europe dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 154. Asia Pacific dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 155. Asia Pacific dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 156. Asia Pacific dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 157. Asia Pacific dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 158. Asia Pacific dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 159. Asia Pacific dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 160. Asia Pacific dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 161. Asia Pacific dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 162. Asia Pacific dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 163. Asia Pacific dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 164. Asia Pacific dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 165. Asia Pacific dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 166. China dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 167. China dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 168. China dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 169. China dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 170. China dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 171. China dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 172. China dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 173. China dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 174. China dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 175. China dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 176. Japan dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 177. Japan dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 178. Japan dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 179. Japan dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 180. Japan dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 181. Japan dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 182. Japan dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 183. Japan dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 184. Japan dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 185. Japan dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 186. India dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 187. India dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 188. India dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 189. India dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 190. India dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 191. India dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 192. India dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 193. India dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 194. India dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 195. India dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 196. Australia dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 197. Australia dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 198. Australia dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 199. Australia dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 200. Australia dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 201. Australia dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 202. Australia dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 203. Australia dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 204. Australia dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 205. Australia dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 206. Rest of Asia Pacific dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 207. Rest of Asia Pacific dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 208. Rest of Asia Pacific dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 209. Rest of Asia Pacific dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 210. Rest of Asia Pacific dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 211. Rest of Asia Pacific dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 212. Rest of Asia Pacific dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 213. Rest of Asia Pacific dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 214. Rest of Asia Pacific dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 215. Rest of Asia Pacific dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 216. Latin America dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 217. Latin America dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 218. Latin America dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 219. Latin America dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 220. Latin America dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 221. Latin America dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 222. Latin America dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 223. Latin America dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 224. Latin America dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 225. Latin America dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 226. Latin America dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 227. Latin America dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 228. Brazil dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 229. Brazil dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 230. Brazil dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 231. Brazil dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 232. Brazil dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 233. Brazil dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 234. Brazil dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 235. Brazil dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 236. Brazil dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 237. Brazil dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 238. Mexico dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 239. Mexico dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 240. Mexico dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 241. Mexico dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 242. Mexico dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 243. Mexico dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 244. Mexico dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 245. Mexico dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 246. Mexico dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 247. Mexico dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 248. Rest of Latin America dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 249. Rest of Latin America dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 250. Rest of Latin America dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 251. Rest of Latin America dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 252. Rest of Latin America dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 253. Rest of Latin America dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 254. Rest of Latin America dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 255. Rest of Latin America dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 256. Rest of Latin America dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 257. Rest of Latin America dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 258. Middle East & Africa dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 259. Middle East & Africa dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 260. Middle East & Africa dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 261. Middle East & Africa dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 262. Middle East & Africa dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 263. Middle East & Africa dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 264. Middle East & Africa dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 265. Middle East & Africa dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 266. Middle East & Africa dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 267. Middle East & Africa dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 268. Middle East & Africa dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 269. Middle East & Africa dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 270. South Africa dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 271. South Africa dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 272. South Africa dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 273. South Africa dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 274. South Africa dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 275. South Africa dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 276. South Africa dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 277. South Africa dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 278. South Africa dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 279. South Africa dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 280. Saudi Arabia dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 281. Saudi Arabia dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 282. Saudi Arabia dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 283. Saudi Arabia dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 284. Saudi Arabia dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 285. Saudi Arabia dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 286. Saudi Arabia dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 287. Saudi Arabia dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 288. Saudi Arabia dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 289. Saudi Arabia dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 290. Rest of Middle East & Africa dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 291. Rest of Middle East & Africa dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 292. Rest of Middle East & Africa dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 293. Rest of Middle East & Africa dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 294. Rest of Middle East & Africa dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 295. Rest of Middle East & Africa dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 296. Rest of Middle East & Africa dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 297. Rest of Middle East & Africa dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 298. Rest of Middle East & Africa dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 299. Rest of Middle East & Africa dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Top-down approach
  • FIG. 3 Market estimation and forecast methodology
  • FIG. 4 Market forecasting methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Dyspepsia drugs industry 360 degree synopsis, 2018 - 2032
  • FIG. 7 Growth potential analysis, by indication
  • FIG. 8 Growth potential analysis, by drug type
  • FIG. 9 Growth potential analysis, by medication
  • FIG. 10 Growth potential analysis, by mode
  • FIG. 11 Growth potential analysis, by distribution channel
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Company matrix analysis, 2023
  • FIG. 15 Competitive analysis of major market players, 2023
  • FIG. 16 Competitive positioning matrix, 2023
  • FIG. 17 Strategic dashboard, 2023